risk assessment in life sciences
TRANSCRIPT
-
8/6/2019 Risk Assessment in Life Sciences
1/34
RISK ASSESSMENT IN LIFE SCIENCES
-
8/6/2019 Risk Assessment in Life Sciences
2/34
What Is Risk Assessment?
Risk assessment is the process of Identifying,
Estimating, and
Evaluating the nature and severity of risks associated with a product.
Risk assessment consists of identifying and characterizing the nature,frequency, and severityof the risks associated with the use of aproduct
Risk management is an iterative process designed to optimize thebenefit-risk balance for regulated products Requires ongoing review and evaluation
-
8/6/2019 Risk Assessment in Life Sciences
3/34
Risk Assessment
-
8/6/2019 Risk Assessment in Life Sciences
4/34
Risk assessment is the actuarial architectural development for valuebase processes ongoing in the organization
Life science validation is all time key vital process to deliver qualityproducts in to the market
The validation process is an extinguishing prominent procedure toimplement the quality driven methodologies to pertain the processparadox
The potential validation requirement commonly includes the GXP andPM of GXP for clearances of concerned regulatory body
-
8/6/2019 Risk Assessment in Life Sciences
5/34
Pharmaceutical validation and R&D validation , Product development
validation and Drug lifecycle validation are comprised areas to have aprofound validating QMS
Of upgrading regulatory demands the flow of validation processmaintenance is defining criticality
Arisen criticality calling for the development of Risk basedValidation and Risk assessment in Life science Validation
-
8/6/2019 Risk Assessment in Life Sciences
6/34
The business objectives achievement for particular pharmacorporations on global scale and to make finest due diligence withthe connected strake holders in paving the demand of definingstrategic solutions with Risk based Validation
Activity, risk factor and risk potential and predictiveassessments of these issues is the major task to provide Risk based
Validation
-
8/6/2019 Risk Assessment in Life Sciences
7/34
How to assess the risks
Step 1: Identify the hazards
Step 2: Decide what might be harmed and how
Step : Evaluate the risks and decide on precautions
Step 4: Record the findings and implement
Step 5: Review the assessment and update
-
8/6/2019 Risk Assessment in Life Sciences
8/34
a hazard is anything that may cause harm, suchas chemicals, electricity, working from ladders,an open drawer etc.
the riskis the chance, high or low, thatsomebody could be harmed by these and otherhazards, together with an indication of howserious the harm could be.
-
8/6/2019 Risk Assessment in Life Sciences
9/34
How the risk is determined
Hazard Identification, aims to determine the qualitativenature of the potential adverse consequences of thecontaminant (chemical, radiation, noise, etc.) and the
strength of the evidence it can have that effect.
Dose-Response Analysis, is determining the relationshipbetween dose and the probability or the incidence of effect(dose-response assessment).
Exposure Quantification, aims to determine the amount of acontaminant (dose) that individuals and populations willreceive.
-
8/6/2019 Risk Assessment in Life Sciences
10/34
Risk Management Process
-
8/6/2019 Risk Assessment in Life Sciences
11/34
Life Sciences Industry Framework
-
8/6/2019 Risk Assessment in Life Sciences
12/34
Life Sciences Industry Framework
-
8/6/2019 Risk Assessment in Life Sciences
13/34
Life Sciences Industry Framework
-
8/6/2019 Risk Assessment in Life Sciences
14/34
Risk & Compliance Intelligence
Corporate Compliance & Governance
Pharmacovigilance
GXPs
Validation
Pre-Approval Safety Assessment
-
8/6/2019 Risk Assessment in Life Sciences
15/34
What is Validation?
According to the Food and Drug Administration (FDA), the goal ofvalidation is to:
establish documented evidence which provides a high degree ofassurance that a specific process will consistently produce aproduct meeting its predetermined specifications and qualityattributes. [1]
-
8/6/2019 Risk Assessment in Life Sciences
16/34
What is Validation?
What does this mean?
An quantitative approach is needed to prove quality,
functionality, and performance of apharmaceutical/biotechnological manufacturing process.
This approach will be applied to individual pieces of equipmentas well as the manufacturing process as a whole.
Guidelines for validation are set by the FDA, but the specifics ofvalidation are determined by the pharmaceutical/biotechcompany.
-
8/6/2019 Risk Assessment in Life Sciences
17/34
To ensure your product, process, or service: is the best it can be
is the best on the market
always performs as expected
continues to grow and/or improve over time
Why Validation?
-
8/6/2019 Risk Assessment in Life Sciences
18/34
Validation Process The V Model
-
8/6/2019 Risk Assessment in Life Sciences
19/34
Validation Master Plan (VMP)
Project Validation Plan (PVP) User Requirements Specification (URS)
Functional Specifications (FS)
Design Specification (DS)
Design Qualification (DQ) Test Protocols
Installation Qualification (IQ)
Operation Qualification (OQ)
Performance Qualification (PQ)
Summary Report(s)
Validation Components
-
8/6/2019 Risk Assessment in Life Sciences
20/34
VMP in the V-Model
-
8/6/2019 Risk Assessment in Life Sciences
21/34
Validation Master Plan (VMP) Defined
Overarching procedural document Illustrates Company commitment to quality
Comprehensive overview of Facilities, Equipment,Processes, Automation, Procedures, & Methods Guide to how validation is performed one approach Defines project responsibilities Defines Validation goals
Description of all equipment, systems, procedures,etc. that fall within scope of validation
Describes approach company will take to identify allmatters that require validation oversight
-
8/6/2019 Risk Assessment in Life Sciences
22/34
-
8/6/2019 Risk Assessment in Life Sciences
23/34
Project Validation Plan - PVP PVP is a:
Structured way to evaluate and communicate the necessaryvalidation elements of a complex project or system
Useful means for driving the project schedule Method for obtaining pre-approval for a lot of work throughstakeholders before investing a lot of time.
Meaningful tool that should be used on a value-added basis
VMP vs. PVP
VMP applies to all validation projects
PVP applies to a specific project
-
8/6/2019 Risk Assessment in Life Sciences
24/34
User Requirements Specifications URS
The most critical document in the process
Purpose To formally document the requirements of a piece of equipment, a
system, or process so we can:
x Demonstrate we understand our processes
x Demonstrate we understand our products
x Demonstrate quality control
x
Ensure all stakeholders that have important knowledge about theprocesses and products are on the same page
-
8/6/2019 Risk Assessment in Life Sciences
25/34
URS in the V-Model
-
8/6/2019 Risk Assessment in Life Sciences
26/34
Types of URS Requirements
Functional - what you want a system to do
Non-functional - restrictions on the types of solutions that areneeded by the user to meet the functional requirements
Design objectives - guides to use in selecting a solution
-
8/6/2019 Risk Assessment in Life Sciences
27/34
Functional URS Requirements
Types of behavior you want the system to perform
If you were buying vehicles for a factory your functionalrequirement might be: Must be able to transport a load from the warehouse to the assembly
building
Similarly for a computer system you define what the system is to
do: The system must store all details of a customer and their order.
-
8/6/2019 Risk Assessment in Life Sciences
28/34
Non-Functional Requirements
Restrictions or constraints to be placed on the system and how tobuild it
Two Main Types of Constraints:
Performance Constraints
How the system should perform when it is delivered
Development Constraints
Project management attributes that can restrict the types of solutionthat can be offered. Three general types:
Time - When a system should be delivered? Resources - How much money is available to develop the system?
Invest time for business staff to brief development staff?
Quality- Any standards which are used to develop the system project management, methods, regulations, consensus standards, etc.
-
8/6/2019 Risk Assessment in Life Sciences
29/34
URS Design Objectives
Become increasingly important during project development
They assist in selecting a solution from the number that areoffered to meet the requirements
Only the Owner knows what is the most important feature of anew system
Compromises are almost always necessary
-
8/6/2019 Risk Assessment in Life Sciences
30/34
Phases of Validation
Validation is broken down into three phases:
x Installation Qualification (IQ)
x Operational Qualification (OQ)x Performance Qualification (PQ)
These three protocols are used to define tests that willdemonstrate that the process consistently and repeatedly
produces the desired product.
-
8/6/2019 Risk Assessment in Life Sciences
31/34
Installation Qualification (IQ)
This is the first step in validation.
This protocol insures that the system/equipment and itscomponents are installed correctly and to the originalmanufacturers specifications.
Calibration of major equipment, accessory equipment, and/orutilities should be performed in this step as well.
-
8/6/2019 Risk Assessment in Life Sciences
32/34
Operational Qualification (OQ)
This step proceeds after the IQ has been performed.
In the OQ, tests are performed on the critical parameters of thesystem/process. These are usually the independent and/ormanipulated variables associated with the system/equipment.
All tests data and measurements must be documented in order toset a baseline for the system/equipment.
-
8/6/2019 Risk Assessment in Life Sciences
33/34
Performance Qualification (PQ)
This is the third and final phase of validation.
This phase tests the ability of the process to perform over longperiods of time within tolerance deemed acceptable.
PQ is performed on the manufacturing process as a whole.
Individual components of the system are not tested individually.
-
8/6/2019 Risk Assessment in Life Sciences
34/34
Thank you